维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

13篇 您的检索式：作者名="Lincoff NS"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Bivalirudin with planned or provisional abciximab versus low dose heparin and abeiximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)显示文摘	Lincoff AM Kleiman NS Kottke-Marchant K	2002	Am Heart J2002，143，5：	1
	2	Bivaliru- din with planned or provisional abciximab wersus low-dose heparin and abciximab during percutaneous coronary revas- cularization: results of the Comparison of Abciximab ComPli- cations with Hirulog for lschemic Events Trial (CACHET)显示文摘	Lincoff AM Kleiman NS Kottke-Marchant K eta/	2002	Am Heart J2002，143，5：	1
	3	Novel treatment for radiation optic neuropathy with intravenous bevacizumab 显示文摘	Farooq O Lincoff NS Saikali N	2012	J Neuroophthalmol2012，32，4：	1
	4	Long-term efficacy of bivalirudin and provisional glycoprotein II b/lll a blockade vs heparin and planned glycoprotein 11 b/I!I a blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial显示文摘	Lincoff AM Kleiman NS Kereiakes D J	2004	JAMA2004，292，6：	1
	5	Long-term efficacy of bivalirudin and provisional glycoprotein Ⅱb/Ⅲa blockade vs hepatin and planned glycoprotein Ⅱb/Ⅲa blockade during percutaneous coronary revascularization : REPLACE-2 randomized trial 显示文摘	Lincoff AM Kleiman NS Kereiakes DJ	2004	JAMA2004，292，6：	1
	6	Long-term efficacy of bivalirudin and provisional glyeoprotein Ⅱb/Ⅲa blockade vs heparin and planned glycoprotein Ⅱb/Ⅲa blockade during pereutaneous coronary revascularization 显示文摘	LINCOFF AM KLEIMAN NS KEREIAKE D J	2004	JAMA2004，292，6：	1
	7	Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization:REPLACE-2 randomized trial显示文摘	Lincoff AM Kleiman NS Kereiakes DJ	2004	JAMA2004，292，6：	1
	8	Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaueous coronary revascularization:results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trim (CACHET)显示文摘	Lincoff AM Kleiman NS Kottke-Marchant K	2002	Am heart J2002，143，5：	1
	9	Long-term efficacyof bivalirudin and provisional glycoprotein II b/ HI a blockade vsheparin and planned glycoprotein II b/HI a blockade during percu-taneous coronary revascularization : REPLACE-2 randomizedtrial显示文摘	Lincoff AM Kleiman NS Kereiakes DJ	2004	JAMA2004，292，6：	1
	10	Comparison of bivalirudin versus heparin during percutaneous coronary intervention(the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events-1 trial)显示文摘	Lincoff AM Bittl JA Kleiman NS	2004	Am J Cardiol2004，93，9：	1
	11	Long-term efficacy of bivalirudin and provisional glycoprotein Ⅱb/Ⅲa blockade vs heparin and planned glycoprotein Ⅱb/Ⅲa blockade during percutaneous coronary revascularization:REPLACE-2 randomized trial显示文摘	Lincoff AM Kleiman NS Kereiakes DJ	2004	JAMA2004，292，：	1
	12	Long-term efficacy of bivalirudin and provisional glycoprotein Ⅱ b/Ⅲ a a blockade vs heparin and planned glycoprotein Ⅱ b/Ⅲ a blockade during percutaneous coronary revascularization : REPLACE-2 randomized trial显示文摘	Lincoff AM Kleiman NS Kereiakes DJ	2004	JAMA2004，292，：	1
	13	The RE-PLACE-1 trial: a pilot study of bivalirudin versusheparin during percutaneous coronary interventionwith stenting and GP Ilb/IIIa blockade free 显示文摘	Lincoff AM Bittl JA Kleiman NS	2002	JAm Coll Cardiol2002，，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费